TEVA
Companies
Nyse American
Teva Pharmaceutical Industries Ltd. ADR
Health Care
$17.06
-$4.98 (-22.60%)
Price Chart
Overview
About TEVA
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Market Cap
$19.1B
Volume
198.6M
Avg. Volume
198.0M
P/E Ratio
4.9061375
Dividend Yield
2.50%
Employees
37.8K
Company Information
Exchange
Nyse American
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Website
Latest News for TEVA
Why Is Teva Stock Trading Higher On Tuesday?
May 27, 2025
Teva CEO on Drug Pricing, Generics, Supply Shortages
January 13, 2025
Teva CEO Richard Francis on tariffs: Well positioned to maintain guidance despite duties
May 7, 2025
Teva Pharmaceuticals CEO talks Trump and US healthcare
January 13, 2025
Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy
June 17, 2025
Risk & Correlation Analysis
Market Correlation
1.03
Moderate Correlation
Volatility
High (0.49)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TEVA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$19.1B
Volume198.6M
P/E Ratio4.91
Dividend Yield2.50%
Important Dates
Next Dividend
December 12, 2017Next Earnings
May 6, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025